AXIN2 and colorectal cancer: Moreover, GBZ strongly reduced the expression of β-catenin target genes at the protein level (AXIN2, Fig. 6d, f) and mRNA level in colorectal cancer cells (AXIN2, LGR5, Fig. 6g).